Membrane lipid composition as new antitumor therapeutic target: sphingomyelin synthase (SGMS) at the basis of Minerval® mechanism of action and design of new Minerval®-related drugs

Projektinformationen

MEMBRANELIPIDTHERAPY

ID Finanzhilfevereinbarung: 627441

Projekt abgebrochen

Startdatum 1 September 2014

Enddatum 2 Mai 2017

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 173 370,60

EU-Beitrag € 173 370,60

Koordiniert durch

UNIVERSITAT DE LES ILLES BALEARS
Spain